European Commission President Ursula von der Leyen announced that the Anglo-Swedish drugmaker would start deliveries one week earlier than scheduled and expand its manufacturing.
The purchasing from India will follow the arrival of the free Covishield vaccine Thursday, which will be accepted by President Rajapaksa at the Colombo airport.
The lack of regulatory clarity coupled with lack of transparency from CDSCO raises questions on the safety and efficacy of the Covid-19 vaccine candidates.
As India gears up to roll out a national vaccination programme, Bharat Biotech and Serum Institute's barbs at each other will only add to vaccine hesitancy.
Dr A K Abdul Momen said that the first consignment of the vaccine co-manufactured by India's Serum Institute is expected to reach Bangladesh towards the end of January.
Bharat Biotech MD Dr Krishna Ella says they gave ‘excellent safety data tested on around 25,000 participants’ & their efficacy data will be available by February-March.
Officials have 'indicated orally' that first 100mn vaccines will be purchased at Rs 200 & a deal should be inked 'in next one or two days', according to Serum CEO Adar Poonawalla.
The UK government has ordered 100 million doses of the Oxford vaccine and scientific advisers have calculated that at least 2 million vaccinations a week could be needed.
MoSPI proposes to remove closed factories from IIP sample, aiming for truer picture of India’s industrial health in upcoming 2022–23 base series. Plan open to public feedback until 25 November.
Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.
COMMENTS